InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 04/01/2019 1:20:38 PM

Monday, April 01, 2019 1:20:38 PM

Post# of 561
News: $CBIO Catalyst Biosciences Receives Orphan Designation from the European Commission for Marzeptacog Alfa (Activated)

SOUTH SAN FRANCISCO, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq: CBIO) today announced that the European Commission has awarded orphan designation of its Factor VIIa (FVIIa) variant marzeptacog alfa (activated) (MarzAA) for the treatment of haemophilia B (...

Got this from https://marketwirenews.com/news-releases/catalyst-biosciences-receives-orphan-designation-from-the-european-commission-for-marzeptacog-alfa-activated--7925162.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CBIO News